Phase IB/II study of alpelisib combined with paclitaxel in patients with PIK3CA-altered metastatic or recurrent gastric cancer. - Kim JW; Yoon S; Ryu MH; Lim SH; Kim ST; Kim TY; Han HS; Jung M; Kim JH; Zang DY; Lee KW (The oncologist, 2026)